# A Pilot Single Dose Crossover Pharmacokinetics Study Of JDP-205 Injection, 10 mg, In Healthy Male And Female Volunteers

> **NCT02045524** · PHASE1 · COMPLETED · sponsor: **JDP Therapeutics, Inc.** · enrollment: 4 (actual)

## Conditions studied

- Acute Urticaria

## Interventions

- **OTHER:** Deep muscle injection
- **OTHER:** Sub-Q Injection

## Key facts

- **NCT ID:** NCT02045524
- **Lead sponsor:** JDP Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2024-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02045524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02045524, "A Pilot Single Dose Crossover Pharmacokinetics Study Of JDP-205 Injection, 10 mg, In Healthy Male And Female Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02045524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*